Tutorials › Statistical Genetics › Linking Regulatory Elements to Genes with Gene Maps

Locus-Level Functional Annotation · Tutorial 661 of 989

Linking Regulatory Elements to Genes with Gene Maps

Use gene maps to distinguish direct promoter overlap, linked regulatory elements, and distance-based clues when proposing candidate target genes for noncoding variants.

Advanced 10 min read

What You'll Learn

  • Read gene maps using transcript start sites, gene bodies, strand, and consistent genomic coordinates
  • Determine when a variant directly overlaps an assigned promoter
  • Trace an enhancer-overlapping variant through an enhancer-to-gene link
  • Calculate distance to a transcription start site and distinguish it from gene-body distance
  • Compare concordant and conflicting evidence without treating a candidate assignment as causal

Why Gene Maps Matter

A noncoding variant can overlap a promoter or enhancer without lying inside the gene it may regulate. To propose a target gene, the variant’s location therefore has to be connected to a gene map: a representation of gene bodies, transcripts, transcription start sites, and, where available, assigned regulatory elements. These maps help organize evidence, but a map-based candidate is not automatically the gene through which a variant affects a trait.

Three kinds of evidence are useful to keep distinct. A variant may directly overlap a promoter assigned to a gene; it may overlap another regulatory element, such as an enhancer, that is linked to a gene; or it may be near a gene by a distance rule. Each supports a different step in the argument. Direct overlap locates the variant in an annotated element, a link connects an element to a gene, and distance provides a positional clue. None alone proves a functional effect.

Reading a Gene Map

Definition: A gene map locates genes and their transcripts along genomic coordinates. A gene body is the genomic span of a gene; a transcript has a transcription start site (TSS), the coordinate at which that transcript begins. The strand indicates the direction of transcription. A promoter is a region assigned to a gene’s transcription start site, often by a stated coordinate window. An enhancer-to-gene link is an annotation connecting a regulatory element to a proposed target gene.

A gene can have several transcripts and therefore several TSSs. A promoter assignment may be made for each transcript, or a resource may select one representative TSS. The same genomic region can consequently overlap a promoter assigned to one transcript but not another. When interpreting an assignment, check which transcript and which promoter definition the map uses; a promoter window is an operational annotation, not a universal boundary shared by all genes.

The strand matters when describing which direction is upstream of a TSS: upstream is toward lower coordinates for a plus-strand transcript and toward higher coordinates for a minus-strand transcript. However, the ordinary absolute distance between a variant and a TSS does not depend on strand. For comparisons in this tutorial, coordinates must refer to the same genome assembly, and interval endpoints must use the same convention. We use zero-based, half-open intervals: an interval \([a,b)\) includes positions from \(a\) up to, but not including, \(b\). A single-base variant at coordinate \(x\) is represented as \([x,x+1)\).

Definition: For a variant at coordinate \(x\) and a gene’s TSS at coordinate \(t\), the absolute TSS distance is \(d_{\mathrm{TSS}}=|x-t|\), measured in base pairs. This is a positional summary, not a measure of regulatory strength. Distance to a gene body is a different quantity: it is zero if the variant lies within the gene’s genomic span and otherwise is the gap to the nearest boundary of that span.

Three Routes from a Variant to a Candidate Gene

For a promoter-overlap assignment, the first question is whether the variant’s base falls in the promoter interval specified by the map. If it does, the variant directly overlaps an element assigned to that gene or transcript. This is more specific than merely being close to a TSS, but it still does not establish that the variant changes promoter activity or affects the trait.

For an enhancer-to-gene assignment, the reasoning has two steps. First, determine whether the variant overlaps an annotated enhancer. Second, check whether that enhancer is linked to a gene in the relevant map or resource. A link might be supported by a particular experimental or computational procedure; its score and interpretation depend on that source. A link score should not be called a probability unless it has specifically been calibrated and defined as one. If an enhancer has links to multiple genes, preserve those alternatives rather than silently choosing one.

Distance-based evidence asks how close the variant is to a gene, often by distance to the TSS. It is useful for describing local genomic context and for generating candidates when stronger links are unavailable. It is not a substitute for an element-to-gene link: regulatory elements can act on genes that are not the nearest by a chosen distance rule. “Nearest gene” also depends on the rule—nearest TSS and nearest gene body need not identify the same gene.

Worked Example: A Variant Overlapping an Assigned Promoter

Suppose a hypothetical variant is at coordinate 500,100. In a gene map on the same assembly, Gene A has a plus-strand transcript with TSS 500,050 and an assigned promoter interval \([499,900,500,200)\). Gene B has a TSS at 500,700 and no promoter interval covering the variant. Does the map support a direct promoter-overlap candidate?

The variant occupies \([500,100,500,101)\). Since \(499,900 \leq 500,100 < 500,200\), this base lies inside Gene A’s assigned promoter interval. The TSS distance is

$$ d_{\mathrm{TSS,A}}=|500{,}100-500{,}050|=50\ \text{bp}. $$

Thus Gene A is supported by direct overlap with its annotated promoter. Gene B is 600 bp from the variant’s coordinate to its TSS, since \(|500{,}100-500{,}700|=600\) bp, but that proximity is not promoter overlap. The result supports proposing Gene A as a promoter-linked candidate; it does not show that the variant alters transcription or that Gene A mediates a trait association.

Checking Element Overlap and Following a Link

Overlap can be checked directly from interval endpoints. For a variant base \([x,x+1)\) and an element interval \([a,b)\), overlap occurs exactly when the intervals share at least one coordinate. For this single-base variant, the condition is \(a \leq x < b\). For two general intervals \([a,b)\) and \([c,d)\), the length of their intersection is \(\max(0,\min(b,d)-\max(a,c))\). This expression is zero if they are disjoint and positive if they overlap.

Justification: The shared portion of \([a,b)\) and \([c,d)\) starts at the later of the two left endpoints, \(\max(a,c)\), and ends at the earlier of the two right endpoints, \(\min(b,d)\). Its length is therefore \(\min(b,d)-\max(a,c)\) when the end is to the right of the start. If the end is not to the right of the start, there is no shared interval, so the length is zero. Combining these cases gives \(\max(0,\min(b,d)-\max(a,c))\).

Worked Example: An Enhancer Link Favors a Non-nearest Candidate

In a hypothetical locus, a variant lies at 2,000,050 and an annotated enhancer occupies \([2,000,000,2,000,120)\). The enhancer-to-gene resource lists a link score of 0.82 for Gene B and 0.31 for Gene A. Their TSS coordinates are 2,001,000 and 1,999,800, respectively. Check the overlap, compare distances, and interpret the link scores.

The variant base is \([2,000,050,2,000,051)\), and \(2,000,000 \leq 2,000,050 < 2,000,120\), so it overlaps the enhancer. The TSS distances are

$$ d_{\mathrm{TSS,A}}=|2{,}000{,}050-1{,}999{,}800|=250\ \text{bp}, \qquad d_{\mathrm{TSS,B}}=|2{,}000{,}050-2{,}001{,}000|=950\ \text{bp}. $$

Gene A is nearer by TSS distance, but the supplied enhancer-link score is higher for Gene B. If the resource defines larger scores as stronger links, the map therefore gives stronger enhancer-link support to Gene B than to Gene A, despite Gene B being farther away. The values 0.82 and 0.31 are scores as given; without a calibration definition, they are not probabilities that either gene is the true target. Both genes remain candidates for follow-up, and the score difference alone does not establish a causal target.

Comparing Evidence Without Collapsing It

These evidence types answer different questions, so a clear interpretation reports them separately. A direct promoter overlap identifies a variant inside an assigned promoter. An enhancer link proposes a gene for an overlapping enhancer. A distance calculation describes spatial proximity. When the clues agree, the assignment is more coherent, but agreement is not independent confirmation if the annotations share underlying data or assumptions. When they disagree, the disagreement should be reported rather than resolved automatically by choosing the nearest gene or the largest uncalibrated score.

EvidenceWhat is checkedWhat it supportsWhat it does not establish
Direct promoter overlapVariant base falls inside a promoter interval assigned to a gene or transcriptThe variant is located in an annotated promoter for that gene or transcriptA regulatory effect, a trait mechanism, or a unique target gene
Enhancer-to-gene linkVariant overlaps an element, and that element has a recorded link to a geneThe linked gene is a proposed target of the overlapping elementThat the link score is a probability or that the variant changes the element
DistanceDistance to a TSS or gene-body boundary under a stated ruleRelative genomic proximityA functional connection or the identity of the affected gene

Worked Example: Distance as a Clue, Not a Link

Consider a hypothetical noncoding variant at coordinate 3,000,500. Gene X has a TSS at 2,999,900, and Gene Y has a TSS at 3,002,000. The map contains no promoter overlap or enhancer-to-gene link for this variant. Which gene is nearest by TSS distance, and what conclusion is warranted?

For Gene X,

$$ d_{\mathrm{TSS,X}}=|3{,}000{,}500-2{,}999{,}900|=600\ \text{bp}. $$

For Gene Y,

$$ d_{\mathrm{TSS,Y}}=|3{,}000{,}500-3{,}002{,}000|=1{,}500\ \text{bp}. $$

Gene X is the nearer gene by the stated TSS rule. Because no direct promoter overlap or element-to-gene link is provided, the map supports only a distance-based candidate designation for Gene X. It does not show that Gene X is the target; Gene Y or another gene could be relevant through regulatory evidence not present in this map.

A Practical Interpretation Sequence

1
Check coordinate compatibility.
Confirm the variant and gene-map annotations use the same genome assembly and coordinate convention. Represent the variant consistently as a base or interval before testing overlap.
2
Inspect assigned promoters.
Identify the transcript or TSS used for each promoter annotation. Record whether the variant base overlaps the stated promoter interval; do not infer overlap from closeness alone.
3
Follow enhancer links when present.
If the variant overlaps an enhancer, list the genes linked to that element and report the resource’s scores according to their stated scale, without treating an uncalibrated score as a probability.
4
Calculate distance as a separate clue.
State whether distance is measured to the TSS or to the gene body, give the result in base pairs, and use “nearest” only relative to that explicit rule.
5
State the strength and limits of the proposal.
Separate observed overlap, recorded links, and positional proximity. Name candidate genes and explain which evidence supports each, without presenting an annotation as proof of causation.

Common Mistake: Treating the Nearest Gene as the Target

A tempting but incorrect argument is: “The variant is closest to Gene A, so Gene A must be its target.” The calculation may correctly identify Gene A as nearest by TSS, but distance alone does not establish a regulatory connection. A variant can overlap an element linked to a more distant gene, and gene-map annotations can also be incomplete or dependent on transcript choice. The correction is to report the nearest gene as a distance-based candidate and keep that evidence distinct from promoter overlap and enhancer-to-gene links.

A second caution is to avoid describing a gene as “the target” when the available evidence only nominates it. A disciplined conclusion might say, “The variant overlaps a promoter assigned to Gene A,” or “The overlapping enhancer has a stronger recorded link score for Gene B than for Gene A.” Those statements accurately describe the map. A causal claim would require evidence beyond positional annotation.

Key takeaway: Use gene maps to connect a variant to genes through explicit promoter assignments or enhancer links, and use distance only as a separately labelled positional clue. Report the coordinate rule, transcript or element assignment, and uncertainty so that a candidate-gene proposal remains proportional to its evidence.

Check Your Understanding

Use the definitions and distinctions in this tutorial to answer the following.

  1. A variant at coordinate 700,020 is compared with a promoter interval \([700,000,700,050)\). Does the variant base overlap that interval under the stated half-open convention?
  2. Why can a variant be nearer to one gene’s TSS while an enhancer-overlap annotation supports a different gene?
  3. What is the difference between distance to a TSS and distance to a gene body?
  4. A resource reports an enhancer-to-gene score of 0.9. What must be known before interpreting this value as a probability?
  5. Write one cautious sentence describing a variant that is nearest to Gene C but has no promoter overlap or enhancer-to-gene link in the available map.
Clinical Biostats